Brief: Histogen Announces Initiation Of Hst 003 Phase 1/2 Trial For Knee Cartilage Regeneration
30/06/2021 13:21
June 30 (Reuters) - Histogen Inc HSTO.O :
* HISTOGEN ANNOUNCES INITIATION OF HST 003 PHASE 1/2 TRIAL
FOR
KNEE CARTILAGE REGENERATION
Source text for Eikon: ID:nGNX1Dt9Wp
Further company coverage: HSTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up